These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 12602818

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma perfusion in myasthenia gravis.
    Passalacqua S, Splendiani G, Sturniolo A, Costanzi S, Barbera G, D'Agostini G, Scoppetta C, Adorno D, DiGiulio S, Casciani C.
    ASAIO Trans; 1988; 34(3):602-5. PubMed ID: 3196571
    [Abstract] [Full Text] [Related]

  • 3. [DFPP in myasthenia gravis: case report].
    Altobelli C, Pollastro RM, Marano E, Capasso G, Anastasio P.
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774582
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Myasthenia gravis exacerbation in association with antibody overshoot following plasmapheresis.
    Ching J, Richards D, Lewis RA, Li Y.
    Muscle Nerve; 2021 Oct; 64(4):483-487. PubMed ID: 34076268
    [Abstract] [Full Text] [Related]

  • 9. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P, Lagoumintzis G, Kostelidou K, Bitzopoulou K, Kordas G, Trakas N, Poulas K, Tzartos SJ.
    J Neuroimmunol; 2008 Sep 15; 201-202():95-103. PubMed ID: 18667243
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous immune globulin in myasthenia gravis.
    Gajdos P.
    Clin Exp Immunol; 1994 Jul 15; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [Abstract] [Full Text] [Related]

  • 17. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF, Wang WX, Xue J, Zhao CB, You HZ, Lu JH, Gu Y.
    Ther Apher Dial; 2010 Apr 15; 14(2):153-60. PubMed ID: 20438536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.